QuidelOrtho Receives De Novo FDA Authorization for COVID Rapid Test
QuidelOrtho has been granted a De Novo request from the U.S. FDA, allowing the company to market its new Sofia 2 SARS Antigen+ FIA.
Read More
Search Results for: covid-19
Enhancing Home COVID Tests with Glow-in-the-Dark Materials
Researchers at the University of Houston are using glow-in-the-dark materials to enhance and improve rapid COVID home tests.
Read More
Agilent and Proscia Partner on Comprehensive Digital Pathology System
Agilent Technologies announced a multi-year distribution agreement with Proscia to offer a comprehensive digital diagnostic pathology system.
Read More
Exhaled Breath Could Diagnose COVID More Accurately
A recent University of Michigan study suggests that a patient’s breath might hold the key to a more precise diagnosis of COVID
Read More
FDA Grants InBios First Marketing Rights for Anthrax POC Test
InBios has been granted the U.S. Food and Drug Administration’s (FDA) first marketing rights for an anthrax point-of-care (POC) test.
Read More